MS4A1 and myeloid sarcoma: Immunohistochemistry studies on post-mortem human brains from HD and people with different disorders (including MS and CNS degenerative diseases) revealed a predominant presence of CD8+ TRM cells [29,30], with enrichment of CD8+CD69+CD20+ TRM compared to peripheral blood [31].